OpenEvidence Launches EvidenceGrade™, Empowering Physicians To See the Strength of Cited Evidence Beneath Each AI Answer
Article excerpt
Highlighted: the sentence this signal was extracted from
MIAMI, July 10, 2026 /PRNewswire/ -- OpenEvidence, America's most widely used medical knowledge platform, today announced EvidenceGrade, a new feature that grades and visualizes, in real time, the quality of the published evidence cited in - and used to inform - every answer. A well-known limitation of AI systems is that when summarizing multiple sources, they gloss over differences in the quality of those sources. In healthcare, this limitation has acute side effects: the difference between evidence from a randomized, blinded, placebo-controlled trial and evidence from a small observational study in a foreign population is the difference between what a physician can plausibly rely on to make a life-or-death treatment decision. EvidenceGrade by OpenEvidence advances medical AI by solving this problem: surfacing, quantifying, grading, and visualizing the quality of the evidence behind OpenEvidence answers - in terms of the safety with which physicians can apply that evidence in real-world clinical practice. EvidenceGrade gives clinicians an at-a-glance view of the strength of the published literature behind an OpenEvidence answer - adding a critical layer of context to aid in incorporating this evidence into high-stakes medical decisions. Developed by physicians and engineers at OpenEvidence, EvidenceGrade is a novel method that builds on the GRADE framework - the...
Keep reading with a free account
The rest of this article, and every signal for OpenEvidence, is in your free account.
